Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Adenocarcinoma of the esophagus: risk factors and prevention.

Heath EI, Limburg PJ, Hawk ET, Forastiere AA.

Oncology (Williston Park). 2000 Apr;14(4):507-14; discussion 518-20, 522-3. Review.

2.

[Reflux, smoking, alcohol. Approach to prevention of esophageal carcinoma].

Rotthauwe J, Lingenfelser T, Malfertheiner P.

MMW Fortschr Med. 2002 Jul 11;144(27-28):26-31. German.

PMID:
12198874
3.

Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent.

Chung CS, Lee YC, Wang CP, Ko JY, Wang WL, Wu MS, Wang HP.

J Formos Med Assoc. 2010 Jun;109(6):408-21. doi: 10.1016/S0929-6646(10)60072-1. Review.

4.

Section I: epidemiological review.

Lukanich JM.

Semin Thorac Cardiovasc Surg. 2003 Apr;15(2):158-66. Review.

PMID:
12838486
5.

Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus.

Achkar JP, Post AB, Achkar E, Carey WD.

Am J Gastroenterol. 1995 Jan;90(1):39-43.

PMID:
7801946
6.

Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.

Wang F, Lv ZS, Fu YK.

Dis Esophagus. 2011 Jul;24(5):318-24. doi: 10.1111/j.1442-2050.2010.01153.x. Epub 2010 Dec 17. Review.

PMID:
21166737
7.

Risk factors for esophageal cancer development.

Falk GW.

Surg Oncol Clin N Am. 2009 Jul;18(3):469-85. doi: 10.1016/j.soc.2009.03.005. Review.

PMID:
19500737
8.

Barrett's esophagus. Reducing the risk of progression to adenocarcinoma.

Reynolds JC, Waronker M, Pacquing MS, Yassin RR.

Gastroenterol Clin North Am. 1999 Dec;28(4):917-45. Review.

PMID:
10695010
9.

Epidemiology of esophageal adenocarcinoma.

Pera M, Manterola C, Vidal O, Grande L.

J Surg Oncol. 2005 Dec 1;92(3):151-9. Review.

PMID:
16299786
10.

Etiology of Barrett's metaplasia and esophageal adenocarcinoma.

Kim R, Weissfeld JL, Reynolds JC, Kuller LH.

Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):369-77. Review.

11.

Racial differences in the histology, location, and risk factors of esophageal cancer.

Chalasani N, Wo JM, Waring JP.

J Clin Gastroenterol. 1998 Jan;26(1):11-3.

PMID:
9492855
12.

Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?

Pondugula K, Wani S, Sharma P.

Curr Gastroenterol Rep. 2007 Dec;9(6):468-74. Review.

PMID:
18377797
13.

Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.

Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF.

J Gastrointest Cancer. 2013 Jun;44(2):143-51. doi: 10.1007/s12029-013-9480-z. Review.

PMID:
23435833
14.

Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.

Leeuwenburgh I, Scholten P, Caljé TJ, Vaessen RJ, Tilanus HW, Hansen BE, Kuipers EJ.

Dig Dis Sci. 2013 Jan;58(1):244-52. doi: 10.1007/s10620-012-2157-9. Epub 2012 Nov 22.

PMID:
23179142
15.

Incidence of adenocarcinoma among patients with Barrett's esophagus.

Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P.

N Engl J Med. 2011 Oct 13;365(15):1375-83. doi: 10.1056/NEJMoa1103042.

16.

Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.

McManus DT, Olaru A, Meltzer SJ.

Cancer Res. 2004 Mar 1;64(5):1561-9. Review.

17.

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.

Anderson LA, Johnston BT, Watson RG, Murphy SJ, Ferguson HR, Comber H, McGuigan J, Reynolds JV, Murray LJ.

Cancer Res. 2006 May 1;66(9):4975-82.

18.

Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.

Kastelein F, Spaander MC, Biermann K, Steyerberg EW, Kuipers EJ, Bruno MJ; Probar-study Group.

Gastroenterology. 2011 Dec;141(6):2000-8; quiz e13-4. doi: 10.1053/j.gastro.2011.08.036. Epub 2011 Aug 28.

PMID:
21878200
19.

Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis.

Thrift AP.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2225-32. doi: 10.1016/j.cgh.2015.03.028. Epub 2015 Mar 31. Review.

PMID:
25835331
20.

Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.

Neumann H, Mönkemüller K, Vieth M, Malfertheiner P.

Dig Dis. 2009;27(1):18-23. doi: 10.1159/000210099. Epub 2009 May 8. Review.

PMID:
19439956

Supplemental Content

Support Center